Biohaven Market Cap 2016-2022 | BHVN
Biohaven market cap history and chart from 2016 to 2022. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Biohaven market cap as of February 03, 2023 is $1.24B.
||Medical - Biomedical and Genetics
Biohaven Ltd. is a clinical-stage biopharmaceutical company. It focuses on discovering and developing therapies for patients with debilitating neurological and neuropsychiatric diseases principally in the United States. Biohaven Ltd., formerly known as BIOHAVEN PHARM, is based in New Haven, Connecticut.